Literature DB >> 16280302

Radiotherapy in multilocalized lymphedema-associated angiosarcoma.

Beate Danz1, Andrea Hellmann, Volker Stadie, Jürgen Dunst, Christine Richter, Wolfgang Ch Marsch, Peter Helmbold.   

Abstract

We report an 80-year-old woman, suffering from a recurrence of a multilocalized lymphedema-associated angiosarcoma of the right arm. The tumor consisted of solid tumor cell formations and "classical" spongiform tumor complexes. In the tumor periphery, pathological endothelial cell proliferates on pre-existing dilated lymphatic capillaries were detectable, which, together with immunohistology (CD 31+/Desmoplakin-1-2.17+/CD 34-), supported the diagnosis of lymphangiosarcoma. Complete remission was achieved under radioimmunotherapy (54 Gy/Interferon beta). A further recurrence 3 months later outside the primary therapy fields was successfully treated with radiotherapy alone. During a follow-up observation period of 3 years, there was neither local recurrence nor metastasis. This case demonstrates for the first time the long-lasting efficacy of photon radiation in a case of histologically-defined lymphangiosarcoma. Further studies should elucidate the suitability of radio monotherapy as first-line therapy in lymphedema-associated angiosarcoma with lymphatic endothelium-like immunohistology.

Entities:  

Mesh:

Year:  2005        PMID: 16280302

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  2 in total

1.  Lymphangiosarcoma of the arm presenting with lymphedema in a woman 16 years after mastectomy: a case report.

Authors:  Yasir J Sepah; Masood Umer; Asim Qureshi; Shaista Khan
Journal:  Cases J       Date:  2009-09-01

2.  Pathological steps of cancer-related lymphedema: histological changes in the collecting lymphatic vessels after lymphadenectomy.

Authors:  Makoto Mihara; Hisako Hara; Yohei Hayashi; Mitsunaga Narushima; Takumi Yamamoto; Takeshi Todokoro; Takuya Iida; Naoya Sawamoto; Jun Araki; Kazuki Kikuchi; Noriyuki Murai; Taro Okitsu; Iori Kisu; Isao Koshima
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.